MATERIALS
All materials used in the study were obtained from Sigma-Aldrich unless specified otherwise.
METHODS

Characterization by 1 H Nuclear Magnetic Resonance ( 1 H NMR) and
Gel Permeation Chromatography (GPC) 1 ran-GMA) were measured by Gel Permeation Chromatography (GPC).
p(HEMA-ran-GMA) characterization results can be found in Figure S2 .
Nanoparticle Synthesis
Synthesis of poly (glycidyl methacrylate) (PGMA) nanoparticles
The synthesis of poly glycidyl methacrylate (PGMA) and the solvent evaporation oil-in-water (O/W) emulsion method to synthesise PGMA nanoparticles, along with the justifications for their use for therapeutic purposes have been previously described extensively. [1] [2] [3] In brief, 100 Known volumes of the nanoparticle suspension were lyophilised for yield assessment, while the remaining suspension was stored at room temperature prior to analyses and further functionalization. 
Nanoparticle Characterisation
Mean hydrodynamic size of the nanoparticle variants were 
Doxorubicin (DOX) Loading into Cy5-Functionalised Nanoparticles
Both nanoparticle variants were loaded with DOX by a "back-filling" method. Blank nanoparticle variants were added to the analysis matrix to serve as controls, alongside test wells containing untreated MCF-7 cells.
Cytotoxicity assessment by MTS Assay
Statistical Analysis
All statistical analyses were conducted using GraphPad Prism 6.0. All presented data is illustrated as the mean, with error bars that represent standard error of the mean (SEM). 
